肝硬化肌少症与经颈静脉肝内门体分流术预后的关系  

Association of sarcopenia with prognosis after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis

作　　者：张帮婷 胥莹[1] 杨雪芳 张雪[1] ZHANG Bangting;XU Ying;YANG Xuefang;Zhang Xue(Department of Gastroenterology,The Second Affiliated Hospital of Kunming Medical University,Kunming 650101,China)

机构地区：[1]昆明医科大学第二附属医院消化内科,昆明650101

出　　处：《临床肝胆病杂志》2021年第12期2932-2934,共3页Journal of Clinical Hepatology

摘　　要：肌少症是肝硬化患者常见且隐匿的并发症,与肝硬化患者的预后密切相关。经颈静脉肝内门体分流术(TIPS)是治疗肝硬化门静脉高压相关并发症的重要手段。越来越多研究表明,肌少症与TIPS治疗肝硬化门静脉高压的预后有关。就国内外关于肌少症及其与TIPS的相关研究进行综述,以探究二者之间的关系,指导临床治疗。Sarcopenia is a common and insidious complication in patients with liver cirrhosis and is closely associated with the prognosis of patients with liver cirrhosis.Transjugular intrahepatic portosystemic shunt(TIPS)is an important method for the treatment of portal hypertension-related complications.More and more studies have shown that sarcopenia is associated with the prognosis of cirrhotic portal hypertension after TIPS.This article reviews the research on sarcopenia and its association with TIPS in China and globally,in order to explore the association between them and guide clinical treatment.

关 键 词：肝硬化 肌减少症 门体分流术 经颈静脉肝内 预后 

分 类 号：R575.2[医药卫生—消化系统]